Antibiotic resistance is tightening its grip on global healthcare, but the pipeline of truly new treatments remains thin.
PSC Biotech partners with Blue Ocean Robotics to distribute the UVD Robot Pharma delivering autonomous UV C disinfection for GMP cleanroom environments.
Zacks Investment Research on MSN
LLY to buy neuroscience biotech Centessa Pharmaceuticals in $7.8B deal
Eli Lilly LLY announced that it has entered into a definitive agreement to acquire U.K.-based Centessa Pharmaceuticals CNTA.
Pharmaceutical regulatory consulting for drug developers and CROs: IND CMC, method validation, NDA strategy, and FDA ...
Zacks Investment Research on MSN
Ultragenyx Pharmaceutical announces FDA acceptance of UX016 IND
Ultragenyx Pharmaceutical RARE announced that the FDA has accepted its investigational new drug (IND) application for UX016, ...
As Founder, Chairman, and Chief Executive Officer of Royalty Pharma plc since its founding in 1996, Pablo Legorreta stands as one of the most consequential and visionary figures in the intersection of ...
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing ...
In today's Pharmaceutical Executive Daily, the Trump administration delays its appeal of the federal ruling blocking RFK ...
Lipella Pharmaceuticals, a biotechnology company in Pittsburgh’s Homewood neighborhood, filed for bankruptcy protection ...
Collegium Pharmaceutical, a leader in abuse-deterrent pain therapies, saw its Chief Commercial Officer trim his stake by more ...
A company wants to develop, package and ship medicine and pharmaceutical supplies from a warehouse-sized building on Route ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results